Latigo Biotherapeutics
Mallory Loflin has extensive experience in clinical development, currently serving as Senior Director of Clinical Development at both Latigo Biotherapeutics, Inc. and Alto Neuroscience. Additionally, Mallory Loflin has worked as a Scientific Advisor in a consulting capacity and previously held the position of Associate Director of Clinical Development at GW Pharmaceuticals plc. This diverse background reflects a strong expertise in guiding clinical programs and strategic development within the biopharmaceutical industry.
This person is not in any offices
Latigo Biotherapeutics
Operator of a drug discovery company intended to develop novel, non-opioid therapies for chronic pain.